US2022015342A1PendingUtilityA1

Gene editing of reproductive hormones to reduce fertility in ictalurus punctatus

Assignee: UNIV AUBURNPriority: Jun 3, 2016Filed: Oct 11, 2021Published: Jan 20, 2022
Est. expiryJun 3, 2036(~9.9 yrs left)· nominal 20-yr term from priority
A01K 2217/075C12N 15/8509A01K 67/0276C07K 14/461C12N 9/22A01K 2267/02A01K 2227/40C12N 15/90A01K 2217/00C12N 15/102C12N 9/222
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are fish with impaired reproductive capacity and methods and compositions for producing the same. The reproductively impaired fish may include catfish, such as Ictalurus punctatus . The disclosed methods may be generally useful for mitigating environmental impact of escaped genetically engineered fish.

Claims

exact text as granted — not AI-modified
1 . A method for reducing fertility in a fish comprising modifying the DNA sequence of said fish's luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene. 
     
     
         2 . The method of  claim 1  wherein the DNA sequence is modified using at least one DNA nuclease. 
     
     
         3 . The method of  claim 2  wherein the DNA nucleases are a zinc finger nuclease, a TALEN nuclease, a CRISPR nuclease, or a combination of zinc finger nucleases, TALEN nucleases, or CRISPR nucleases. 
     
     
         4 . The method of  claim 1  wherein the modification to said fish's DNA¬¬ comprises deletions, insertions, base changes, or combinations of any one of these in the DNA sequence. 
     
     
         5 . A method for inducing modifications to a nucleic acid sequence in a living cell comprising electroporating at least two times to deliver at least one plasmid encoding at least one DNA nuclease. 
     
     
         6 . The method of  claim 5  wherein at least one DNA nuclease is a zinc finger nuclease, a TALEN nuclease, a CRISPR nuclease, or a combination of zinc finger nucleases, TALEN nucleases, or CRISPR nucleases. 
     
     
         7 . The method of  claim 6  wherein the DNA nuclease binds to a nucleic acid sequence that is at least 80% similar to SEQ ID NOs:1, 2, 3, 12, 13, 14, 15, or 16. 
     
     
         8 . The method of  claim 5  wherein the modification to the DNA comprises base changes, deletions or insertions in the sequence of said living cell, wherein the DNA comprises the luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene. 
     
     
         9 . A fish with a modified luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene such that functional luteinizing hormone, Gonadotropin-releasing hormone, or follicle-stimulating hormone gene product is no longer produced. 
     
     
         10 . The fish of  claim 9  wherein modifications to the fish's luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone genes comprise deletions, insertions, base changes, or combinations of any one of these in the native gene sequence. 
     
     
         11 . The fish of  claim 10  wherein the deletions or insertions are in or near nucleic acid sequences with at least 80% similar to SEQ ID NOs:1, 2, 3, 12, 13, 14, 15, or 16. 
     
     
         12 . A DNA vector encoding at least one DNA nuclease that binds to the catfish luteinizing hormone, gonadotropin-releasing hormone, or follicle-stimulating hormone gene sequence. 
     
     
         13 . The vector of  claim 12  wherein the at least one DNA, nuclease is comprised of a zinc finger nuclease, a TALEN nuclease, or a CRISPR nuclease. 
     
     
         14 . The vector of  claim 12  wherein the DNA nuclease binds to a nucleic acid sequence that is at least 80% similar to SEQ ID NOs:1, 2, 3, 12, 13, 14, 15, or 16.

Join the waitlist — get patent alerts

Track US2022015342A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.